Roles of FHIT and WWOX fragile genes in cancer
- 28 January 2006
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 232 (1), 27-36
- https://doi.org/10.1016/j.canlet.2005.06.048
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Hypermethylation patterns in theFhit regulatory region are tissue specificMolecular Carcinogenesis, 2005
- Components of DNA Damage Checkpoint Pathway Regulate UV Exposure–Dependent Alterations of Gene Expression of FHIT and WWOX at Chromosome Fragile SitesMolecular Cancer Research, 2005
- Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancerOncogene, 2005
- 17β-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivoOncogene, 2004
- WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteinsOncogene, 2004
- CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumorsOncogene, 2004
- Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workersOncogene, 2002
- FRA3B and other common fragile sites: the weakest linksNature Reviews Cancer, 2001
- A 350-kb Cosmid Contig in 3p14.2 That Crosses the t(3;8) Hereditary Renal Cell Carcinoma Translocation Breakpoint and 17 Aphidicolin-Induced FRA3B BreakpointsGenomics, 1996
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979